ResearcherHarbin Medical UniversityActive in the last 2 years
Xinlei Zou
Matched on OpenAlex author ID A5051753659. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2023: 2 papers · 2024: 1 paper
Papers 3
- Advances in Drug Therapy for Metastatic Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.7150/jca.89788↗
- Exosomal miRNAs in the microenvironment of pancreatic cancer. Co-author DOI 10.1016/j.cca.2023.117360↗
- Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy. Co-author DOI 10.3389/fimmu.2023.1222719↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jianjun Gao · 3 shared papers, 2023–2024 · strength 0.57
- Paper Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy. DOI 10.3389/fimmu.2023.1222719↗
- Paper Exosomal miRNAs in the microenvironment of pancreatic cancer. DOI 10.1016/j.cca.2023.117360↗
- Paper Advances in Drug Therapy for Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.7150/jca.89788↗
- Yunfu Cui · 3 shared papers, 2023–2024 · strength 0.57
- Paper Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy. DOI 10.3389/fimmu.2023.1222719↗
- Paper Exosomal miRNAs in the microenvironment of pancreatic cancer. DOI 10.1016/j.cca.2023.117360↗
- Paper Advances in Drug Therapy for Metastatic Pancreatic Ductal Adenocarcinoma. DOI 10.7150/jca.89788↗
- Xiangyu Zhong · 2 shared papers, 2023 · strength 0.40
- Yi Xu · 1 shared paper, 2023 · strength 0.18
- Haolin Bao · 1 shared paper, 2024 · strength 0.18
- Xiangyu Zhong · 1 shared paper, 2024 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.